Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jost Klawitter

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Expert Opinion on Drug Safety|April 28, 2015
Everolimus and sirolimus in transplantation-related but differentJost Klawitter, Björn Nashan, Uwe Christians
Therapeutic Drug Monitoring|September 30, 2015
Biomarkers in Transplantation--Proteomics and MetabolomicsUwe Christians, Jelena Klawitter, Jost Klawitter
Transplant International : Official Journal of the European Society for Organ Transplantation|June 27, 2003
Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the ratNatalie Serkova, Jost Klawitter, Claus U Niemann
Current Pharmaceutical Biotechnology|April 7, 2011
How unbiased is non-targeted metabolomics and is targeted pathway screening the solution?Uwe Christians, Jelena Klawitter, Andrea Hornberger, et al.
Microchemical Journal : Devoted to the Application of Microtechniques in All Branches of Science|May 7, 2013
Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?Uwe Christians, Jacek Klepacki, Touraj Shokati, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2011
Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptionsUwe Christians, Jost Klawitter, Jelena Klawitter, et al.
Breast Cancer Research : BCR|March 9, 2010
Effects of lovastatin on breast cancer cells: a proteo-metabonomic studyJelena Klawitter, Touraj Shokati, Vanessa Moll, et al.
Rapid Communications in Mass Spectrometry : RCM|January 25, 2011
Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be comparedJelena Klawitter, Manuel Haschke, Touraj Shokati, et al.
Analytical Biochemistry|May 4, 2007
Development and validation of an assay for the quantification of 11 nucleotides using LC/LC-electrospray ionization-MSJost Klawitter, Volker Schmitz, Jelena Klawitter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2015
A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urineJacek Klepacki, Jost Klawitter, Jelena Klawitter, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Safety|April 28, 2015
Everolimus and sirolimus in transplantation-related but differentJost Klawitter, Björn Nashan, Uwe Christians
Therapeutic Drug Monitoring|September 30, 2015
Biomarkers in Transplantation--Proteomics and MetabolomicsUwe Christians, Jelena Klawitter, Jost Klawitter
Transplant International : Official Journal of the European Society for Organ Transplantation|June 27, 2003
Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the ratNatalie Serkova, Jost Klawitter, Claus U Niemann
Current Pharmaceutical Biotechnology|April 7, 2011
How unbiased is non-targeted metabolomics and is targeted pathway screening the solution?Uwe Christians, Jelena Klawitter, Andrea Hornberger, et al.
Microchemical Journal : Devoted to the Application of Microtechniques in All Branches of Science|May 7, 2013
Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?Uwe Christians, Jacek Klepacki, Touraj Shokati, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2011
Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptionsUwe Christians, Jost Klawitter, Jelena Klawitter, et al.
Breast Cancer Research : BCR|March 9, 2010
Effects of lovastatin on breast cancer cells: a proteo-metabonomic studyJelena Klawitter, Touraj Shokati, Vanessa Moll, et al.
Rapid Communications in Mass Spectrometry : RCM|January 25, 2011
Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be comparedJelena Klawitter, Manuel Haschke, Touraj Shokati, et al.
Analytical Biochemistry|May 4, 2007
Development and validation of an assay for the quantification of 11 nucleotides using LC/LC-electrospray ionization-MSJost Klawitter, Volker Schmitz, Jelena Klawitter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2015
A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urineJacek Klepacki, Jost Klawitter, Jelena Klawitter, et al.
Pageof 11